PrimeRFP SCOUT · Federal Contract Recompete Brief

HHSN27200031NIAID preclinical development support — Advanced Bioscience Laboratories, Inc

Advanced Bioscience Laboratories, Inc holds $41.8M across 70 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 2 related awards under parent HHSN272201100021I. Recompete timing centers on the Mar 31, 2028 PoP end — agencies typically plan 12–18 months ahead.

National Institutes Of Health Niaid

Awarding office

Advanced Bioscience Laboratories, Inc

Recipient

Mar 31, 2028

PoP end

$521K

Obligated

$9.5M

Potential

541712

NAICS

AN81

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Advanced Bioscience Laboratories, Inc — $90

Contract facts

Federal

Contract numberHHSN27200031

Also listed asHHSN272201100021I-HHSN27200031

AgencyNational Institutes Of Health Niaid

Awarding officeNational Institutes Of Health Niaid

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentAdvanced Bioscience Laboratories, Inc

CAGE4KCY8

UEIMK4QC9EKZXG8

NAICS541712

No full NAICS 541712 intel page yet. Browse NAICS intelligence

PSCAN81

Parent IDIQ / IDVHHSN272201100021I

Place of performanceROCKVILLE MD

Pricing typeCost Plus Fixed Fee

Extent competedFull And Open Competition

PoP startSep 12, 2016

PoP end (current)Mar 31, 2028

Obligated$521K

Current value$9.5M

Potential value$9.5M

NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF CGMP NATIVE FLEXIBLY LINKED HIV-1 ENVELOPE PROTEIN is a federal award for National Institutes Of Health Niaid held by Advanced Bioscience Laboratories, Inc. Estimated value $9.5M ($521K obligated). Current period of performance ends Mar 31, 2028. Place of performance: ROCKVILLE MD.

NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF CGMP NATIVE FLEXIBLY LINKED HIV-1 ENVELOPE PROTEIN

Recompete timing

Public

● Expiring in 589 days

Current PoP ends Mar 31, 2028 (589 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Oct 1, 2026.

Incumbent footprint

Public record

Advanced Bioscience Laboratories, Inc — $41.8M obligated across 70 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$41.8M · 100% of firm total

Open full company profile →

Related awards

Same parent · incumbent

HHSN27200004

CGMP PRODUCTION OF HIV-1 ENVELOPE (ENV) BULK HARVEST

$42.4M

Dec 31, 2026

HHSN27200002

SIMIAN VACCINE EVALUATION UNITS

$34.9M

Dec 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract HHSN27200031?

HHSN27200031 (NIAID preclinical development support) is a National Institutes Of Health Niaid award with a potential value of $9.5M, currently held by Advanced Bioscience Laboratories, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded HHSN27200031?

National Institutes Of Health Niaid awarded HHSN27200031 to Advanced Bioscience Laboratories, Inc (potential $9.5M).

Who is the incumbent on HHSN27200031?

Advanced Bioscience Laboratories, Inc is the incumbent with $41.8M across 70 related awards in SCOUT’s public footprint. The current period of performance ends Mar 31, 2028.

When does Advanced Bioscience Laboratories, Inc’s HHSN27200031 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 31, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Jul 30, 2025